Ce mode d'administration du produit pourrait effectivement dclencher un bronchospasme, soit une rduction de la taille des bronches
Science 281 : 18601863 Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T and Ichijo H (2001) ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
2,3 Correction of deficiency different routes of administration Depending on the cause of the deficiency, different strategies to correct it can be applied, although in conventional medical practice the most common treatment is intramuscular (i.m.) injection of B12
SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis
Oral supplements may appear cheaper per unit but require significantly higher doses, which can offset the initial cost advantage
HPLC and mass-spectrometry verified, Certificate of Analysis with every batch